Financials data is unavailable for this security.
View more
Year on year Guangzhou Jet Bio-Filtration Co Ltd 's revenues fell -24.06% from 609.82m to 463.10m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from 87.71m to 34.79m, a -60.34% decrease.
| Gross margin | 37.71% |
|---|---|
| Net profit margin | 13.60% |
| Operating margin | 16.38% |
| Return on assets | 4.41% |
|---|---|
| Return on equity | 6.14% |
| Return on investment | 4.68% |
More ▼
Cash flow in CNYView more
In 2023, Guangzhou Jet Bio-Filtration Co Ltd increased its cash reserves by 17.70%, or 54.87m. The company earned 134.81m from its operations for a Cash Flow Margin of 29.11%. In addition the company used 67.43m on investing activities and also paid 17.95m in financing cash flows.
| Cash flow per share | -- |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 8.32 |
|---|---|
| Tangible book value per share | 7.94 |
More ▼
Balance sheet in CNYView more
| Current ratio | 9.13 |
|---|---|
| Quick ratio | 7.82 |
| Total debt/total equity | 0.3049 |
|---|---|
| Total debt/total capital | 0.2333 |
More ▼
Growth rates in CNY
Year on year, growth in dividends per share increased 1.49% while earnings per share excluding extraordinary items fell by -60.34%. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally, five year annualized earnings per share growth ranks below the industry average relative to its peers.
| Div yield(5 year avg) | -- |
|---|---|
| Div growth rate (5 year) | -- |
| Payout ratio (TTM) | 14.10% |
| EPS growth(5 years) | -14.20 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 388.87 |
More ▼
